Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]European Organisation for Research and Treatment of Cancer"
Count: 405
Selected: 0
| NCT ID | Title |
|---|
| NCT02218801 | A Prospective Colorectal Liver Metastasis Database With an Integrated Quality Assurance Program | ||
| NCT02781935 | Diffusion-Weighted MRI for Liver Metastasis | ||
| NCT01880359 | AF CRT +/- Nimorazole in HNSCC | ||
| NCT04031677 | Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma | ||
| NCT01979393 | IRCI Gynae Sarcomas, High Grade Uterine Sarcoma | ||
| NCT03763422 | Trial in Low Grade Glioma Patients: Wait or Treat | ||
| NCT02194842 | Phase III Radium 223 mCRPC-PEACE III | ||
| NCT01101425 | Male Breast Cancer: Understanding the Biology for Improved Patient Care | ||
| NCT03609047 | Adjuvant Palbociclib in Elderly Patients With Breast Cancer | ||
| NCT00626990 | Phase III Trial of Anaplastic Glioma Without 1p/19q LOH | ||
| NCT03345095 | A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma | ||
| NCT05259605 | Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification | ||
| NCT04128072 | Anti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB) in Patients With Stage IB-IIB Cutaneous T-Cell Lymphoma | ||
| NCT03859453 | Follow-up in Early and Locally Advanced Breast Cancer Patients | ||
| NCT03515993 | Follow-up in Gynecological Cancer Survivors | ||
| NCT04790253 | PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study) | ||
| NCT02799706 | Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer | ||
| NCT02659384 | Anti-programmed Cell Death-1 Ligand 1 (aPDL-1) Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Recurrent Platinum Resistant Ovarian Cancer | ||
| NCT01969578 | Androgen Deprivation Therapy in Advanced Salivary Gland Cancer | ||
| NCT02984410 | Study Assessing The "Best of" Radiotherapy vs the "Best of" Surgery in Patients With Oropharyngeal Carcinoma | ||
| NCT03437200 | Combination of Chemoradiation With Immunotherapy in Inoperable œsophageal Cancer | ||
| NCT03134118 | Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM) | ||
| NCT04127110 | Activity of Lorlatinib Based on ALK Resistance Mutations Detected on Blood in ALK Positive NSCLC Patients | ||
| NCT04498767 | Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE) | ||
| NCT02834884 | SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access | ||
| NCT02205047 | Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma | ||
| NCT02580994 | Pembrolizumab in Untreated Extensive SCLC | ||
| NCT02172872 | "InDACtion" vs "3+7" Induction in AML | ||
| NCT01524926 | CREATE: Cross-tumoral Phase 2 With Crizotinib | ||
| NCT01402271 | Pazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer | ||
| NCT00379041 | Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma | ||
| NCT00005584 | Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma | ||
| NCT00002462 | RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease | ||
| NCT05724602 | Radiotherapy Plus Xevinapant in Older Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma | ||
| NCT04402073 | Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed Medulloblastoma | ||
| NCT00049595 | Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma | ||
| NCT04933942 | Phase II Trial of Romiplostim for Thrombocytopenia Induced by Lomustine at First Progression of MGMT Promoter-meth Glioblastoma | ||
| NCT01597414 | Elderly Metastatic Breast Cancer: Pertuzumab-Herceptin vs Pertuzumab-Herceptin-Metronomic Chemotherapy, Followed by T-DM1 | ||
| NCT00433589 | Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph Nodes | ||
| NCT02436733 | Pleurectomy/ Decortication (P/D) Preceded or Followed by Chemotherapy in Patients With Early Stage MPM | ||
| NCT03770468 | Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma | ||
| NCT02856893 | Osimertinib Treatment on EGFR T790M Plasma Positive NSCLC Patients (APPLE) | ||
| NCT05512364 | TREAT ctDNA Elacestrant | ||
| NCT04218825 | REACH: Study to Determine the Aetiology of Chlormethine Gel Induced-skin Drug Reaction in Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL) | ||
| NCT03443856 | Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for Recurrence | ||
| NCT02214134 | SPECTAlung: Screening Patients With Thoracic Tumors for Efficient Clinical Trial Access | ||
| NCT03260712 | Pembrolizumab in Biliary Tract Cancer | ||
| NCT01723969 | Screening Platform for Clinical Trials in Advanced Colorectal Cancer | ||
| NCT04780464 | A 3 Arm Randomized Study on Health-related QoL of Elderly Patients With Advanced Soft Tissue Sarcoma | ||
| NCT03357224 | PARCT: Trial of Atezolizumab in Relapsed/Refractory Cutaneous T Cell Lymphoma (CTCL) |
